about
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for TherapyThe Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαCancer cell redirection biomarker discovery using a mutual information approachCUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinasesActivation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition.Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R.MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradationTargeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: Which combination makes the whole greater than the sum of its parts?Mechanism-based cancer therapy: resistance to therapy, therapy for resistance.VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.Breast cancer prevention: lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells.Complexity galore: 3D cultures, biomechanics and systems medicine at the eighth ENBDC workshop "Methods in Mammary Gland Development and Cancer".‘The charmingest place’: non-coding RNA, lineage tracing, tumor heterogeneity, metastasis and metabolism--new methods in mammary gland development and cancer: the fifth ENBDC Workshop.Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.RNA Expression Profiling Reveals Differentially Regulated Growth Factor and Receptor Expression in Redirected Cancer Cells.SHP2 regulates proliferation and tumorigenicity of glioma stem cells.Tackling Resistance to PI3K Inhibition by Targeting the Epigenome.Stimulating translational research: several European life science institutions put their heads together.European Network of Breast Development and Cancer turned 10 years: a growing family of mammary gland researchersActivating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 OncogenesGlucocorticoids promote breast cancer metastasisThe Eleventh ENBDC Workshop: Advances in Technology Help to Unveil Mechanisms of Mammary Gland Development and Cancerogenesis
P50
Q28085626-8BD7BD0C-BC96-4279-A65E-C84AD860C4B3Q28596581-49CB6483-994D-465E-8856-769A3489DFC2Q33778794-FD7F6D78-8286-4A47-A8CC-64853D908B59Q36601460-D08257A1-5722-4547-858D-3EBAC2A00617Q36765341-6E239204-8FA2-4F35-B3DD-83D2C7D57316Q37275769-89C39929-6938-47DF-AEDD-B67483B35B97Q37689443-D8870EC1-2BEB-43CD-A39F-B34F570456B7Q38156315-8C204739-4F41-40EC-A4C0-0947ADB7A2DFQ38255064-C4F8DA2E-59E9-4277-9B93-7139ACEC8DD4Q39035290-9AE736B2-F99D-4395-98B2-775886B75A6AQ39042184-440ADCF2-7EDA-4033-967D-79264681FA19Q39057246-CF95F5C7-38B9-44A3-AA23-8E7C24E03FA9Q41498742-6CAA19A5-9D6D-46F2-ADF9-CC576C231065Q42363169-7B89A3B3-0B9B-4B9B-B187-948824666F87Q42368744-56345771-D861-4E34-B0A3-57A738AAF64CQ47648738-BCAE3E1E-E438-49E9-B7C7-08527A9E7BE0Q47882579-5EA79E5E-00B1-423E-9001-0E9636AEE4B4Q47885098-92DA9BDF-3269-42E2-8C75-4B0EC06D4F4BQ51012990-EC0788F2-10C8-4BBE-80A8-0D23C7E4C391Q52863411-24C8D16E-E96B-4B29-8AFE-86E7966F2946Q58765719-EEE567B1-77DF-44BA-AF8C-8D346F396D7CQ90365185-A069CF25-BCFC-49AB-8C69-608ED13557A2Q92342096-AE794BDE-9E02-40C2-AF09-28E506F57951Q93173435-1B128767-8ADE-4FD1-8322-06AF4E806CC9
P50
description
researcher
@en
name
Mohamed Bentires-Alj
@en
type
label
Mohamed Bentires-Alj
@en
prefLabel
Mohamed Bentires-Alj
@en
P31
P496
0000-0001-6344-1127